SEC Filing Summary: Pro-Pharmaceuticals, Inc.
Business Context and Reporting Period
This Form 8-K was filed by Pro-Pharmaceuticals, Inc. on May 14, 2010. The filing addresses an administrative correction regarding the company's 2009 fiscal year Form 10-K Annual Report, originally filed on March 12, 2010. The registrant is incorporated in Nevada with principal executive offices in Newton, Massachusetts.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a procedural filing and does not contain financial performance data.
Material Changes
The sole material event reported is the amendment of the Consent of Independent Registered Public Accounting Firm (Caturano and Company, P.C.). The amendment corrects an inadvertent omission by adding a reference to the Company's Form S-8 Registration Statement no. 333-159247.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or discussion of unusual items. It is strictly limited to the correction of the accounting firm's consent document.
Key Facts for Investor Verification
- Verify the amended Exhibit 23.1 (Consent of Caturano and Company, P.C.) to confirm the inclusion of Form S-8 Registration Statement no. 333-159247.
- Confirm that the original Form 10-K for the 2009 fiscal year remains otherwise unchanged.
- Note that the signature date on the document appears as May 14, 2009, while the report date is May 14, 2010; verify if this is a clerical error in the source text.